A new medication for high cholesterol costs $3,500 per year whereas the older medication costs $500 per year. Assuming the treatment needs to be taken from ages 70-79 and increases the age at death from 85 to 85.3 years, what is the cost per life-year saved? Now also assume that quality of life past age 85 is 0.8. What is the cost per quality-adjusted life year saved? Now also assume that a new study shows that the medication improves quality of life past age 85 from 0.8 to 0.9. What does this imply about the cost per quality-adjusted-life-year saved?

A new medication for high cholesterol costs $3,500 per year whereas the older medication costs $500 per year. Assuming the treatment needs to be taken from ages 70-79 and increases the age at death from 85 to 85.3 years, what is the cost per life-year saved? Now also assume that quality of life past age 85 is 0.8. What is the cost per quality-adjusted life year saved? Now also assume that a new study shows that the medication improves quality of life past age 85 from 0.8 to 0.9. What does this imply about the cost per quality-adjusted-life-year saved?

EBK HEALTH ECONOMICS AND POLICY

7th Edition

ISBN:9781337668279

Author:Henderson

Publisher:Henderson

Chapter4: Economic Evaluation In Health Care

Section: Chapter Questions

Problem 10QAP

See similar textbooks

Similar questions

there is a reduced cost of minus 65 on ETV. I like to say this means if we made ETV = 1 when it was 0 in the optimal solution, then the exposure quality would fall by 65. Another interpretation (that I am not a big fan of, but perfectly acceptable) is if the objective function exposure quality of 90 changes by 65 ETV will not be 0. Should the 90 be 25 or 155?
Assume a patient has a particular disease. The quality weight (q) associated with the disease is 0.5, meaning the patient has 0.5 quality-adjusted life year (QALY) from living one year with the disease. The patient with such a disease can only live for 10 years (without treatment). Now a drug has been developed to treat this disease. With the drug, the quality of life (q) can be improved to 0.8 and patients can live for 15 years. (1) Calculate the QALYs gained due to the treatment (relative to no treatment). Assume no discounting of future years. Please show all your calculations (points will be deduced if the answer contains only one number without steps). (2) If the drug costs $49,000, what is the incremental cost-effectiveness ratio of the treatment compared with no treatment? Please show all your calculations (points will be deduced if the answer contains only one number without steps). (3) Assume it is agreed that a QALY is worth $5000 (the patient is willing to pay up to $5000…
It is well established that indoor air quality (IAQ) has a significant effect on general health and productivity of employees at a workplace. A study showed that enhancing IAQ by increasing the building ventilation from 5 cfm (cubic feet per minute) to 20 cfm increased the productivity by 0.25 percent, valued at $90 per person per year, and decreased the respiratory illnesses by 10 percent for an average annual savings of $39 per person while increasing the annual energy consumption by $6 and the equipment cost by about $4 per person per year (ASHRAE Journal, December 1998). For a workplace with 120 employees, determine the net monetary benefit of installing an enhanced IAQ system to the employer per year.
Under intervention A, the status quo, 15% of 3-year-old children in the country of Granada die from Dengue and under intervention B, a new intervention only 10% of children in Granada die from Dengue. The life expectancy at three years in Dengue is 55 years. The cost of intervention A is $100 and the cost of intervention B is $185. What is the incremental cost-effectiveness ratio (ICER) comparing intervention B to intervention A expressed as a. cost per life-years b. cost per life-years saved
It costs $1,000 to produce one pill and $1,002 to produce two pills. The incremental cost of a pill is $501. True or False?
Global passenger traffic demand was down by 58.4 per cent over pre-pandemic 2019 levels with the Omicron variant of Covid-19 hindering recovery, according to full-year results for 2021 released by the International Air Transport Association (IATA). IATA said 2021 results were however an improvement compared to 2020 when full-year RPKs (revenue passenger kilometres or RPKs) were down 65.8 per cent against 2019. IATA expects the January-February period to be weaker due to Omicron travel restrictions, which slowed the recovery in international demand by about two weeks in December. More specifically, – international passenger demand in 2021 was 75.5 per cent below 2019 levels – capacity fell by 65.3 per cent – load factor dropped by 24.0 percentage points to 58.0 per cent – domestic demand was down 28.2 per cent compared to 2019 – domestic capacity shrunk by 19.2 per cent – domestic load factor dropped 9.3 percentage points to 74.3 per cent. Looking at December 2021, total…
Global passenger traffic demand was down by 58.4 per cent over pre-pandemic 2019 levels with the Omicron variant of Covid-19 hindering recovery, according to full-year results for 2021 released by the International Air Transport Association (IATA). IATA said 2021 results were however an improvement compared to 2020 when full-year RPKs (revenue passenger kilometres or RPKs) were down 65.8 per cent against 2019. IATA expects the January-February period to be weaker due to Omicron travel restrictions, which slowed the recovery in international demand by about two weeks in December. More specifically, – international passenger demand in 2021 was 75.5 per cent below 2019 levels – capacity fell by 65.3 per cent – load factor dropped by 24.0 percentage points to 58.0 per cent – domestic demand was down 28.2 per cent compared to 2019 – domestic capacity shrunk by 19.2 per cent – domestic load factor dropped 9.3 percentage points to 74.3 per cent. Looking at December 2021, total traffic was…
Consider two treatments. Treatment 1 saves six years of quality adjusted life at a cost of $90,000. Treatment 2 saves three years of quality adjusted life at a cost of $60,000. Which treatment is preferred from a cost utility analysis perspective?
Hand written solution is not allowed
A company manufactures screwdrivers and has fixed costs of SEK 3,400,000 and variable costs per screwdriver of SEK 6. These costs are not assumed to change with varying production volumes. According to company policy, the sales price is set at double the purchase price.The company's production capacity for screwdrivers is 900,000, but the target for production is for various strategic reasons set at a utilization rate of 70%. Calculate the company's safety margin in SEK, when the utilization rate has been reached and all produced screwdrivers have been sold.
An adverse materials price variance of £1,001 has been reported for the period. Actual expenditure on materials was £20,251 and 1,540 kg were purchased. What must be the standard cost per kg? £13.15 £13.50 £12.50 £13.80
this assessment correct? what would be the interpretation to answer this question? If capacity for producing the A2B timer component is in fact limited, and therefore each sale of the household timer will eliminate the sale of an A2B component, how would you measure the household timer’s profitability?